These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25214781)

  • 21. Tumor Priming by SMO Inhibition Enhances Antibody Delivery and Efficacy in a Pancreatic Ductal Adenocarcinoma Model.
    Wang J; Chan DKW; Sen A; Ma WW; Straubinger RM
    Mol Cancer Ther; 2019 Nov; 18(11):2074-2084. PubMed ID: 31363010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theranostic nanoparticles for detection and treatment of pancreatic cancer.
    Agarwal H; Bynum RC; Saleh N; Harris D; MacCuaig WM; Kim V; Sanderson EJ; Dennahy IS; Singh R; Behkam B; Gomez-Gutierrez JG; Jain A; Edil BH; McNally LR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(4):e1983. PubMed ID: 39140128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced expression of fibroblast growth factor receptor 2 IIIc promotes human pancreatic cancer cell proliferation.
    Ishiwata T; Matsuda Y; Yamamoto T; Uchida E; Korc M; Naito Z
    Am J Pathol; 2012 May; 180(5):1928-41. PubMed ID: 22440254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo activity of the low-immunogenic antimesothelin immunotoxin RG7787 in pancreatic cancer.
    Hollevoet K; Mason-Osann E; Liu XF; Imhof-Jung S; Niederfellner G; Pastan I
    Mol Cancer Ther; 2014 Aug; 13(8):2040-9. PubMed ID: 24928849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma.
    Damhofer H; Medema JP; Veenstra VL; Badea L; Popescu I; Roelink H; Bijlsma MF
    Mol Oncol; 2013 Dec; 7(6):1031-42. PubMed ID: 23998958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells.
    Sebens Müerköster S; Werbing V; Sipos B; Debus MA; Witt M; Grossmann M; Leisner D; Kötteritzsch J; Kappes H; Klöppel G; Altevogt P; Fölsch UR; Schäfer H
    Oncogene; 2007 Apr; 26(19):2759-68. PubMed ID: 17086212
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.
    Adamska A; Domenichini A; Capone E; Damiani V; Akkaya BG; Linton KJ; Di Sebastiano P; Chen X; Keeton AB; Ramirez-Alcantara V; Maxuitenko Y; Piazza GA; De Laurenzi V; Sala G; Falasca M
    J Exp Clin Cancer Res; 2019 Aug; 38(1):312. PubMed ID: 31378204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance-guided regional gene delivery strategy using a tumor stroma-permeable nanocarrier for pancreatic cancer.
    Wang Q; Li J; An S; Chen Y; Jiang C; Wang X
    Int J Nanomedicine; 2015; 10():4479-90. PubMed ID: 26203245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Pancreatic Ductal Adenocarcinoma (PDAC).
    Parrasia S; Zoratti M; Szabò I; Biasutto L
    Cell Physiol Biochem; 2021 Jan; 55(1):61-90. PubMed ID: 33508184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.
    Long KB; Tooker G; Tooker E; Luque SL; Lee JW; Pan X; Beatty GL
    Mol Cancer Ther; 2017 Sep; 16(9):1898-1908. PubMed ID: 28611107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches.
    Carvalho TMA; Di Molfetta D; Greco MR; Koltai T; Alfarouk KO; Reshkin SJ; Cardone RA
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCK Receptor Inhibition Reduces Pancreatic Tumor Fibrosis and Promotes Nanoparticle Delivery.
    Abraham T; Armold M; McGovern C; Harms JF; Darok MC; Gigliotti C; Adair B; Gray JL; Kelly DF; Adair JH; Matters GL
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38790986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic Cancer Chemoresistance to Gemcitabine.
    Amrutkar M; Gladhaug IP
    Cancers (Basel); 2017 Nov; 9(11):. PubMed ID: 29144412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing an immunocompromised porcine model of human cancer for novel therapy development with pancreatic adenocarcinoma and irreversible electroporation.
    Hendricks-Wenger A; Aycock KN; Nagai-Singer MA; Coutermarsh-Ott S; Lorenzo MF; Gannon J; Uh K; Farrell K; Beitel-White N; Brock RM; Simon A; Morrison HA; Tuohy J; Clark-Deener S; Vlaisavljevich E; Davalos RV; Lee K; Allen IC
    Sci Rep; 2021 Apr; 11(1):7584. PubMed ID: 33828203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Gemcitabine-Re(I) Bisquinolinyl Complex Combinations and Formulations With Liquid Crystalline Nanoparticles for Pancreatic Cancer Photodynamic Therapy.
    Liew HS; Mai CW; Zulkefeli M; Madheswaran T; Kiew LV; Pua LJW; Hii LW; Lim WM; Low ML
    Front Pharmacol; 2022; 13():903210. PubMed ID: 35873548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Nonapoptotic Programmed Cell Death - Ferroptosis, Necroptosis, and Pyroptosis - in Pancreatic Ductal Adenocarcinoma Treatment.
    Hsu SK; Chu YH; Syue WJ; Lin HY; Chang WT; Chen JY; Wu CY; Yen CH; Cheng KC; Chiu CC
    Front Oncol; 2022; 12():872883. PubMed ID: 35664778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine.
    Huai Y; Zhang Y; Xiong X; Das S; Bhattacharya R; Mukherjee P
    Cell Stress; 2019 Jul; 3(8):267-279. PubMed ID: 31440741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noninvasive Visualization of Obesity-Boosted Inflammation in Orthotopic Pancreatic Ductal Adenocarcinoma Using an Octapod Iron Oxide Nanoparticle.
    Xu T; Xu X; Yang L; Chen X; Ju S
    ACS Appl Bio Mater; 2020 Sep; 3(9):6408-6418. PubMed ID: 35021772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.